- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/12 - Antidiarrhoeals
Patent holdings for IPC class A61P 1/12
Total number of patents in this class: 1032
10-year publication summary
|
48
|
66
|
76
|
75
|
84
|
85
|
78
|
64
|
70
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9987 |
22 |
| Finch Therapeutics Holdings, LLC | 71 |
22 |
| Takeda Pharmaceutical Company Limited | 2721 |
17 |
| N.V. Nutricia | 1094 |
17 |
| Napo Pharmaceuticals, Inc. | 40 |
14 |
| University of Florida Research Foundation, Inc. | 4147 |
13 |
| Albireo AB | 175 |
13 |
| Nestec S.A. | 2587 |
11 |
| DSM IP Assets B.V. | 5430 |
9 |
| Array BioPharma Inc. | 458 |
9 |
| Cedars-Sinai Medical Center | 1189 |
8 |
| The Regents of the University of California | 20556 |
7 |
| Ajinomoto Co., Inc. | 2276 |
7 |
| Novartis AG | 10345 |
6 |
| Abbott Laboratories | 2289 |
6 |
| The Johns Hopkins University | 5821 |
6 |
| Compagnie Gervais Danone | 879 |
6 |
| Meiji Co., Ltd. | 738 |
6 |
| Thetis Pharmaceuticals LLC | 23 |
6 |
| Novozymes A/S | 3346 |
5 |
| Other owners | 822 |